Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123383 | PMC |
| http://dx.doi.org/10.1016/j.hrcr.2021.05.004 | DOI Listing |
Publication Analysis
Top Keywords
remdesivir-induced symptomatic
4
symptomatic bradycardia
4
bradycardia treatment
4
treatment covid-19
4
covid-19 disease
4
remdesivir-induced
1
bradycardia
1
treatment
1
covid-19
1
disease
1
Similar Publications
Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.
Cureus
July 2022
Internal Medicine, University of Kentucky College of Medicine, Lexington, USA.
Remdesivir has been extensively employed during the coronavirus disease 2019 (COVID-19) pandemic as it has proven to be efficacious against the causative SARS-CoV-2. However, there is not much evidence on the cardiovascular adverse effect profile of remdesivir. In addition, limited data support the occurrence of sinus bradycardia associated with remdesivir.
View Article and Find Full Text PDFRemdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease.
HeartRhythm Case Rep
August 2021
Department of Electrophysiology, HCA Healthcare/USF Morsani College of Medicine GME Programs at Regional Medical Center Bayonet Point, Hudson, Florida.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!